Clinical use of praziquantel in China.

Fu, S; Xiao, S H; Catto, B A

Fu, S; Xiao, S H; Catto, B A.

Afiliación

Fu S; Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, 207 Rui fin Er Lu, Shanghai, Peoples Republic of China.

Parasitol Today ; 4(11): 312-5, 1988 Nov.

Article en En | MEDLINE | ID: mdl-15463013

RESUMEN

Praziquantel, a broad-spectrum anthelmintic developed by E. Merck and Bayer AG in Germany in the early 1970s, was synthesized in the People's Republic of China in 1977 and given the Chinese name Pyquiton. After a series of pharmacological and toxicological studies in China, praziquantel was released for clinical use in 1978. The drug is now available for treatment of human schistosome and other trematode infections as well as the treatment of cestode infections including cysticercosis. However, much of the clinical work has been published in Chinese journals that may not be universally familiar. This article summarizes some of the key aspects of these reports, dealing with the clinical use of praziquantel against schistosomiasis japonica and other helminth infections in China.

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Parasitol Today Asunto de la revista: PARASITOLOGIA Año: 1988 Tipo del documento: Article Pais de publicación: Reino Unido

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links